期刊文献+

巨噬细胞功能障碍与糖尿病慢性难愈创面的关系 被引量:6

Role of dysfunction of macrophage in intractable diabetic wound
原文传递
导出
摘要 创面愈合包括凝血和炎症反应、组织形成以及组织成熟和重塑3个连续、重叠的阶段^[1],巨噬细胞在此过程中发挥重要作用^[2],调控表皮的KC、Fb等创面修复细胞功能的有序发挥^[3-6]。 As a result of the stimulation of proinflammatory mediators,circulating peripheral-blood mononuclear cells migrate into the wound area,and they differentiate into different phenotypes of macrophage to take different roles in healing process.Their phenotypes interchange under different microenvironments.The disturbance of cutaneous environment in diabetic patients has been shown to alter the quantity,morphology,and functions of the macrophages resulting in retardation of wound healing.Healing of intractable diabetic wound can be improved by the supplement of exogenous growth factors,which might improve healing process by regulating the phenotype of macrophage in intractable diabetic wound.This article reviews the relationship between intractable diabetic wound and macrophage to explore new methods of treating intractable diabetic wound.
出处 《中华烧伤杂志》 CAS CSCD 北大核心 2014年第3期264-269,共6页 Chinese Journal of Burns
基金 国家自然科学基金(81170761、81270909)
关键词 糖尿病 巨噬细胞 伤口愈合 异质性 Diabetes mellitus Macrophages Wound healing Heterogeneity
  • 相关文献

参考文献53

  • 1Gurtner GC, S Werner S, Barrandon Y, et al. Wound repair and regeneration [ J ]. N ature, 2008, 453 ( 7193 ) : 314-321.
  • 2Peppa M, Stavroulakis P, Raptis SA. Advanced glycoxidation products and impaired diabetic wound healing [ J ]. Wound Repair Regen, 2009,17(4) : 461-472.
  • 3Rodero MP, Khosrotehrani K. Skin wound healing modulation by macrophages[ J]. Int J Clin Exp Pathol, 2010,3(7) : 643-653.
  • 4Rahat MA, Bitterman H, Lahat N. Molecular mechanisms regu- lating maerophage response to hypoxia [ J ]. Front Immunol, 2011. 2. 45.
  • 5Mahdavian Delavary B, van der Veer WM, van Egmond M, et al. Macrophages in skin injury and repair[J]. Immunobiology, 2011, 216(7): 753-762.
  • 6Odegaard JI, Chawla A. Alternative macrophage activation and metabolism[ J]. Annu Rev Pathol, 2011, 6 : 275-297.
  • 7Gordon S, Taylor PR. Monocyte and macrophage heterogeneity [J]. Nat Revlmmunol, 2005, 5(12): 953-964.
  • 8Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes[ J]. J Clin Invest, 2007, 117 (5) : 1219- 1222.
  • 9Brancato SK, Albina JE. Wound macrophages as key regulators of repair: origin, phenotype, and function[ J]. Am J Pathol, 2011,178(1) : 19-25.
  • 10Gordon S. Alternative activation of macrophages [ J]. Nat Rev Immunol, 2003, 3(1): 23-35.

二级参考文献22

  • 1Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest,2007,117 (5) : 1249 - 1259.
  • 2Laing T , Hanson R , Chan F , et al . The role of endothelial dysfunction in the pathogenesis of impaired diabetic wound healing: a novel therapeutic target? Med Hypotheses, 2007,69 (5) :1029 - 1031.
  • 3Martin A , Komada M , Sane D . Abnormal angiogenesis in diabetic mellitus. Med Res Rev, 2003,23 (2) : 117 - 145.
  • 4Suh W, Kim KL, Kim JM, et al. Transplantation of endothelial progenitor cells accelerates dermal wound healing with increased recruitment of monocytes/macrophages and neovascularization. Stem Cells,2005,23 (10) : 1571 - 1578.
  • 5Jacobi J , Jang JJ , Sundram U , et al . Nicotine accelerates angiogenesis and wound healing in genetically diabetic mice. Am J Pathol,2002,161 ( 1 ) :97 - 104.
  • 6Springer ML , lp TK , Blau HM . Angiogenesis monitored by perfusion with a space-filling microbead suspension. Mol Ther, 2000,1(1) :82 -87.
  • 7Frykberg RG . Diabetic foot ulcers : pathogenesis and management. Am Fam Physician ,2002, 66 (9) : 1655 - 1662.
  • 8Jain RK. Molecular regulation of vessel maturation. Nat Med, 2003, 9(6): 685-693.
  • 9Falanga V . Wound healing and its impairment in the diabetic foot. Lancet ,2005,366 ( 9498 ) : 1736 - 1743.
  • 10Esposito C, Fasoli G, Platin AR, et al. Long-term exposure to high glucose up regulates VCAM-induced endothelial cell adhesiveness to PBMC. Kidney Int, 2001,59 (5) :1842 - 1849.

共引文献6

同被引文献83

  • 1付小兵.进一步重视体表慢性难愈合创面发生机制与防治研究[J].中华创伤杂志,2004,20(8):449-451. 被引量:121
  • 2Mirza R, Koh TJ. Dysregulation of nmnocyte/macrophage phenotype in woundsof' diabetic mice [J]. Cytoklne, 2011, 56(2): 256- 264.
  • 3Bitto A, Altavilla D, Pizzino G, et al. Inhibition of inflammasome activation improves the impaired pattern of healing in genetically diabetic mice [J]. Br J Pharmacol, 2014, 171 (9) : 2300-2307.
  • 4Martinon F, Burns K, Tsehopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of prolL- beta [J]. Mol Cell, 2002, 10(2): 417-426.
  • 5Tschopp J, Martinon F, Burns K. NALPs: a novel protein family involved in inflammation [ J 1. Nat Rev Mol Cell Biol, 2003,4 (2) : 95-104.
  • 6Artlett CM. The Role of the NLRP3 Inflammasome in Fibrosis [ J]. IOpen Rbeumatol J, 2012, 6: 80-86.
  • 7Mcneela EA, Burke A, Neill D R, et al. Pneumo|ysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4 [J~. PEnS Pathog, 2010, 6 ( 11 ): el001191.
  • 8Mori MA, Bezy O, Kahn CR. Metabolic syndrome: is Nlrp3 inflanmmsome a trigger or a target of insulin resistance ~ Jl. Circ Res, 2011, 108(10) : 1160-1162.
  • 9Franchi L, Mcdonald C, Kanneganti TD, et al. Nucleotide-binding oligomerization domain- like receptors : intracellular pattern recognition molecules for pathogen detection and host defense [l]. l hnmunol, 2006, 177(6): 3507-3513.
  • 10Franchi L, Eigeubrud T, Mufioz-Planillo R, et al. The inflammasome: a caspase-l-activation plath)rm that regulates imnmne responses and disease pathogenesis [ J 1. Nat hnmunol, 2009, 10(3) : 241-247.

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部